Credit Suisse analyst Alethia Young lifted her price target on Ascendis Pharma (Nasdaq: ASND) from $30.00 to $50.00 sending the stock price soaring $6.50 to close at $34.24.
Price target lifted on Ascendis Pharma
September 22, 2017 at 19:13 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|